John J Mccabe - Net Worth and Insider Trading

John J Mccabe Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John J Mccabe owns 5 companies in total, including Sesen Bio Inc (SESN) , Interleukin Genetics Inc (ILIU) , and SatCon Technology Corp (SATCQ) among others .

Click here to see the complete history of John J Mccabe’s form 4 insider trades.

Insider Ownership Summary of John J Mccabe

Ticker Comapny Transaction Date Type of Owner
SESN Sesen Bio Inc 2015-07-03 See Remarks
ILIU Interleukin Genetics Inc 2006-02-07 Chief Accounting Officer
SATCQ SatCon Technology Corp 2003-07-24 Chief Accounting Officer
LIMIT LIMIT 2018-01-25 Vice President & Finance
LIMIT LIMIT 2015-07-03 See Remarks

John J Mccabe Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John J Mccabe Ownership Network

Ownership Network List of John J Mccabe

No Data

Ownership Network Relation of John J Mccabe

Insider Network Chart

John J Mccabe Owned Company Details

What does Sesen Bio Inc do?

Who are the key executives at Sesen Bio Inc?

John J Mccabe is the See Remarks of Sesen Bio Inc. Other key executives at Sesen Bio Inc include 10 percent owner Modernatx, Inc. , director & President and CEO Steven Kelly , and Chief Financial Officer Richard Steven Morris .

Sesen Bio Inc (SESN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sesen Bio Inc (SESN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sesen Bio Inc (SESN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sesen Bio Inc (SESN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sesen Bio Inc Insider Transactions

No Available Data

John J Mccabe Mailing Address

Above is the net worth, insider trading, and ownership report for John J Mccabe. You might contact John J Mccabe via mailing address: C/o Eleven Biotherapeutics, Inc., 215 First Street, Suite 400, Cambridge Ma 02142.